| mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.9 |
| mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
0.0081 |
0.9 |
| mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
0.0071 |
0.9 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |